Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Investing Activities (2020 - 2022)

Bio Essence has reported Cash from Investing Activities over the past 3 years, most recently at -$5527.0 for Q4 2022.

  • For Q4 2022, Cash from Investing Activities rose 93.85% year-over-year to -$5527.0; the TTM value through Dec 2023 reached -$147427.0, up 5.77%, while the annual FY2024 figure was -$114.0, 96.85% up from the prior year.
  • Cash from Investing Activities for Q4 2022 was -$5527.0 at Bio Essence, up from -$52053.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$5527.0 in Q4 2022 and troughed at -$89847.0 in Q4 2021.
  • A 3-year average of -$25732.0 and a median of -$9020.0 in 2021 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: crashed 1463.1% in 2021 and later skyrocketed 93.85% in 2022.
  • Year by year, Cash from Investing Activities stood at -$5748.0 in 2020, then crashed by 1463.1% to -$89847.0 in 2021, then skyrocketed by 93.85% to -$5527.0 in 2022.
  • Business Quant data shows Cash from Investing Activities for BIOE at -$5527.0 in Q4 2022, -$52053.0 in Q3 2022, and -$89847.0 in Q4 2021.